Publications
-
Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.
Fu JJ,
Zaller ND, Yokell MA, Bazazi AR, Rich JD.
J Subst Abuse Treat.
2013 May-Jun;
44
(5):
502-5
-
Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose.
Yokell MA,
Zaller ND, Green TC, McKenzie M, Rich JD.
J Opioid Manag.
2012 Jan-Feb;
8
(1):
63-6
-
HIV infection and risk of overdose: a systematic review and meta-analysis.
Green TC,
McGowan SK, Yokell MA, Pouget ER, Rich JD.
AIDS.
2012;
26
(4):
403-17
-
Prescription drug monitoring programs.
Yokell MA,
Green TC, Rich JD.
JAMA.
2012;
307
(9):
912; author reply 912-3
-
Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.
Zaller ND,
Yokell MA, Nayak SM, Fu JJ, Bazazi AR, Rich JD.
J Urban Health.
2012;
89
(4):
659-70
-
Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.
Yokell MA,
Zaller ND, Green TC, Rich JD.
Curr Drug Abuse Rev.
2011;
4
(1):
28-41
-
Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.
Bazazi AR,
Yokell M, Fu JJ, Rich JD, Zaller ND.
J Addict Med.
2011;
5
(3):
175-80
-
Opioid Overdose Prevention and Naloxone Distribution in Rhode Island
Yokell MA,
Green TC, Bowman S, McKenzie M, Rich JD.
Med Health RI.
2011;
94
(8):
240-242
-
Adverse event associated with a change in nonprescription syringe sale policy.
Zaller ND,
Yokell MA, Jeronimo A, Bratberg JP, Case P, Rich JD.
J Am Pharm Assoc (2003).
2010 Sep-Oct;
50
(5):
619-22
Help